Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines.
Kubota
M
M
Department of Pediatrics, Kyoto University, Japan.
Takimoto
T
T
Kitoh
T
T
Tanizawa
A
A
Akiyama
Y
Y
Kiriyama
Y
Y
Mikawa
H
H
D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism*; D001088:Arabinonucleotides / Q000378:metabolism*; D003561:Cytarabine / Q000378:metabolism*; D003841:Deoxycytidine / Q000378:metabolism; D003845:Deoxycytosine Nucleotides / Q000032:analysis; D004357:Drug Synergism; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D007938:Leukemia / Q000378:metabolism*; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology*; D013942:Thymine Nucleotides / Q000032:analysis; D014407:Tumor Cells, Cultured
D001088:Arabinonucleotides; D003845:Deoxycytosine Nucleotides; D013942:Thymine Nucleotides; D003561:Cytarabine; D003841:Deoxycytidine; D001085:Arabinofuranosylcytosine Triphosphate; C024107:2'-deoxycytidine 5'-triphosphate; C024157:thymidine 5'-triphosphate; D006918:Hydroxyurea; D008727:Methotrexate